{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T11:42:03Z","timestamp":1792496523816,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T00:00:00Z","timestamp":1784419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"vor","delay-in-days":93,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-62325-5","type":"journal-article","created":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T00:16:14Z","timestamp":1784420174000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Red blood cell-derived parameters as a potential tool in the differential diagnosis of parkinsonian syndromes"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8685-475X","authenticated-orcid":false,"given":"Natalia","family":"Madetko-Alster","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dagmara","family":"Otto-\u015alusarczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bartosz","family":"Migda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patryk","family":"Chunowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Struga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Alster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,19]]},"reference":[{"key":"62325_CR1","doi-asserted-by":"publisher","unstructured":"Tysnes, O. B. & Storstein, A. Epidemiology of Parkinson\u2019s disease. J. Neural Transm. 124(8), 901\u2013905. https:\/\/doi.org\/10.1007\/s00702-017-1686-y (2017) (Epub 2017 Feb 1).","DOI":"10.1007\/s00702-017-1686-y"},{"issue":"12","key":"62325_CR2","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma, R. B. et al. MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov. Disord. 30(12), 1591\u20131601. https:\/\/doi.org\/10.1002\/mds.26424 (2015).","journal-title":"Mov. Disord"},{"key":"62325_CR3","doi-asserted-by":"publisher","unstructured":"H\u00f6glinger, G. U. et al. Movement Disorder Society-endorsed PSP Study Group. Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria. Mov. Disord. 32(6), 853\u2013864. https:\/\/doi.org\/10.1002\/mds.26987 (2017) (Epub 2017 May 3).","DOI":"10.1002\/mds.26987"},{"key":"62325_CR4","doi-asserted-by":"publisher","first-page":"180","DOI":"10.3389\/fneur.2020.00180","volume":"11","author":"P Alster","year":"2020","unstructured":"Alster, P., Madetko, N., Koziorowski, D. & Friedman, A. Progressive supranuclear palsy-parkinsonism predominant (PSP-P)-a clinical challenge at the boundaries of PSP and Parkinson\u2019s disease (PD). Front. Neurol. 11, 180. https:\/\/doi.org\/10.3389\/fneur.2020.00180 (2020).","journal-title":"Front. Neurol."},{"issue":"3","key":"62325_CR5","doi-asserted-by":"publisher","first-page":"656","DOI":"10.3390\/cells10030656","volume":"10","author":"D Koziorowski","year":"2021","unstructured":"Koziorowski, D. et al. Mechanisms of neurodegeneration in various forms of parkinsonism-similarities and differences. Cells 10(3), 656. https:\/\/doi.org\/10.3390\/cells10030656 (2021).","journal-title":"Cells"},{"issue":"6","key":"62325_CR6","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.cell.2010.02.016","volume":"140","author":"CK Glass","year":"2010","unstructured":"Glass, C. K., Saijo, K., Winner, B., Marchetto, M. C. & Gage, F. H. Mechanisms underlying inflammation in neurodegeneration. Cell 140(6), 918\u2013934. https:\/\/doi.org\/10.1016\/j.cell.2010.02.016 (2010).","journal-title":"Cell"},{"issue":"7","key":"62325_CR7","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1038\/s41590-023-01522-0","volume":"24","author":"AS Mendiola","year":"2023","unstructured":"Mendiola, A. S. et al. Defining blood-induced microglia functions in neurodegeneration through multiomic profiling. Nat. Immunol. 24(7), 1173\u20131187. https:\/\/doi.org\/10.1038\/s41590-023-01522-0 (2023).","journal-title":"Nat. Immunol."},{"key":"62325_CR8","doi-asserted-by":"publisher","first-page":"893","DOI":"10.3389\/fnins.2020.00893","volume":"14","author":"P Alster","year":"2020","unstructured":"Alster, P., Madetko, N., Koziorowski, D. & Friedman, A. Microglial activation and inflammation as a factor in the pathogenesis of progressive supranuclear palsy (PSP). Front. Neurosci. 14, 893. https:\/\/doi.org\/10.3389\/fnins.2020.00893 (2020).","journal-title":"Front. Neurosci."},{"key":"62325_CR9","doi-asserted-by":"publisher","first-page":"1360195","DOI":"10.3389\/fncel.2024.1360195","volume":"18","author":"MG Mayer","year":"2024","unstructured":"Mayer, M. G. & Fischer, T. Microglia at the blood brain barrier in health and disease. Front. Cell. Neurosci. 18, 1360195. https:\/\/doi.org\/10.3389\/fncel.2024.1360195 (2024).","journal-title":"Front. Cell. Neurosci."},{"issue":"1","key":"62325_CR10","doi-asserted-by":"publisher","first-page":"5816","DOI":"10.1038\/s41467-019-13812-z","volume":"10","author":"K Haruwaka","year":"2019","unstructured":"Haruwaka, K. et al. Dual microglia effects on blood brain barrier permeability induced by systemic inflammation. Nat. Commun. 10(1), 5816. https:\/\/doi.org\/10.1038\/s41467-019-13812-z (2019).","journal-title":"Nat. Commun."},{"key":"62325_CR11","doi-asserted-by":"publisher","first-page":"1347987","DOI":"10.3389\/fnagi.2024.1347987","volume":"16","author":"A Adamu","year":"2024","unstructured":"Adamu, A., Li, S., Gao, F. & Xue, G. The role of neuroinflammation in neurodegenerative diseases: current understanding and future therapeutic targets. Front. Aging Neurosci. 16, 1347987. https:\/\/doi.org\/10.3389\/fnagi.2024.1347987 (2024).","journal-title":"Front. Aging Neurosci."},{"key":"62325_CR12","doi-asserted-by":"publisher","first-page":"1376545","DOI":"10.3389\/fendo.2024.1376545","volume":"15","author":"A Gialluisi","year":"2024","unstructured":"Gialluisi, A. et al. Blood-based biological ageing and red cell distribution width are associated with prevalent Parkinson\u2019s disease: findings from a large Italian population cohort. Front. Endocrinol. 15, 1376545. https:\/\/doi.org\/10.3389\/fendo.2024.1376545 (2024).","journal-title":"Front. Endocrinol."},{"issue":"17","key":"62325_CR13","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1212\/WNL.0b013e3181bd80c1","volume":"73","author":"R Savica","year":"2009","unstructured":"Savica, R. et al. Anemia or low hemoglobin levels preceding Parkinson disease: a case-control study. Neurology 73(17), 1381\u20131387. https:\/\/doi.org\/10.1212\/WNL.0b013e3181bd80c1 (2009).","journal-title":"Neurology"},{"issue":"5","key":"62325_CR14","doi-asserted-by":"publisher","first-page":"623","DOI":"10.3390\/brainsci11050623","volume":"11","author":"JH Kim","year":"2021","unstructured":"Kim, J. H. et al. The association between anemia and Parkinson\u2019s disease: a nested case-control study using a national health screening cohort. Brain Sci. 11(5), 623. https:\/\/doi.org\/10.3390\/brainsci11050623 (2021).","journal-title":"Brain Sci."},{"key":"62325_CR15","unstructured":"Tian, G., Zhou, R., Guo, X. & Li, R. Alteration of peripheral blood cell profiles in Parkinson\u2019s disease: a retrospective case-control study [abstract]. Mov. Disord. 37(suppl 2) (2022)."},{"issue":"5","key":"62325_CR16","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s40292-024-00662-0","volume":"31","author":"A Garc\u00eda-Escobar","year":"2024","unstructured":"Garc\u00eda-Escobar, A. et al. Red blood cell distribution width is a biomarker of red cell dysfunction associated with high systemic inflammation and a prognostic marker in heart failure and cardiovascular disease: A potential predictor of atrial fibrillation recurrence. High. Blood Press. Cardiovasc. Prev. 31(5), 437\u2013449. https:\/\/doi.org\/10.1007\/s40292-024-00662-0 (2024) (Epub 2024 Jul 20).","journal-title":"High. Blood Press. Cardiovasc. Prev."},{"issue":"6","key":"62325_CR17","doi-asserted-by":"publisher","first-page":"e3552","DOI":"10.1002\/brb3.3552","volume":"14","author":"P Alster","year":"2024","unstructured":"Alster, P., Otto-\u015alusarczyk, D., Wierci\u0144ska-Drapa\u0142o, A., Struga, M. & Madetko-Alster, N. The potential significance of hepcidin evaluation in progressive supranuclear palsy. Brain Behav. 14(6), e3552. https:\/\/doi.org\/10.1002\/brb3.3552 (2024).","journal-title":"Brain Behav."},{"issue":"7","key":"62325_CR18","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1172\/JCI15686","volume":"110","author":"G Nicolas","year":"2002","unstructured":"Nicolas, G. et al. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J. Clin. Invest. 110(7), 1037\u20131044. https:\/\/doi.org\/10.1172\/JCI15686 (2002).","journal-title":"J. Clin. Invest."},{"issue":"20","key":"62325_CR19","doi-asserted-by":"publisher","first-page":"15135","DOI":"10.3390\/ijms242015135","volume":"24","author":"N Madetko-Alster","year":"2023","unstructured":"Madetko-Alster, N. et al. Clinical phenotypes of progressive supranuclear palsy-the differences in interleukin patterns. Int. J. Mol. Sci. 24(20), 15135. https:\/\/doi.org\/10.3390\/ijms242015135 (2023).","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"62325_CR20","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1093\/brain\/awab103","volume":"144","author":"GP Williams","year":"2021","unstructured":"Williams, G. P. et al. CD4 T cells mediate brain inflammation and neurodegeneration in a mouse model of Parkinson\u2019s disease. Brain 144(7), 2047\u20132059. https:\/\/doi.org\/10.1093\/brain\/awab103 (2021).","journal-title":"Brain"},{"key":"62325_CR21","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3389\/fneur.2019.00013","volume":"10","author":"E Storelli","year":"2019","unstructured":"Storelli, E., Cassina, N., Rasini, E., Marino, F. & Cosentino, M. Do Th17 lymphocytes and IL-17 contribute to Parkinson\u2019s disease? A systematic review of available evidence. Front. Neurol. 10, 13. https:\/\/doi.org\/10.3389\/fneur.2019.00013 (2019).","journal-title":"Front. Neurol."},{"issue":"8","key":"62325_CR22","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1007\/s10072-017-2988-4","volume":"38","author":"S Jiang","year":"2017","unstructured":"Jiang, S., Gao, H., Luo, Q., Wang, P. & Yang, X. The correlation of lymphocyte subsets, natural killer cell, and Parkinson\u2019s disease: a meta-analysis. Neurol. Sci. 38(8), 1373\u20131380. https:\/\/doi.org\/10.1007\/s10072-017-2988-4 (2017) (Epub 2017 May 11).","journal-title":"Neurol. Sci."},{"issue":"10","key":"62325_CR23","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1002\/mds.28685","volume":"36","author":"L Mu\u00f1oz-Delgado","year":"2021","unstructured":"Mu\u00f1oz-Delgado, L. et al. Peripheral immune profile and neutrophil-to-lymphocyte ratio in Parkinson\u2019s disease. Mov. Disord. 36(10), 2426\u20132430. https:\/\/doi.org\/10.1002\/mds.28685 (2021) (Epub 2021 Jun 8).","journal-title":"Mov. Disord"},{"issue":"2","key":"62325_CR24","doi-asserted-by":"publisher","first-page":"148","DOI":"10.5603\/PJNNS.a2022.0014","volume":"56","author":"N Madetko","year":"2022","unstructured":"Madetko, N. et al. Platelet-to-lymphocyte ratio and neutrophil-tolymphocyte ratio may reflect differences in PD and MSA-P neuroinflammation patterns. Neurol. Neurochir. Pol. 56(2), 148\u2013155. https:\/\/doi.org\/10.5603\/PJNNS.a2022.0014 (2022) (Epub 2022 Feb 4).","journal-title":"Neurol. Neurochir. Pol."},{"issue":"12","key":"62325_CR25","doi-asserted-by":"publisher","first-page":"e16451","DOI":"10.1111\/ene.16451","volume":"31","author":"L Mu\u00f1oz-Delgado","year":"2024","unstructured":"Mu\u00f1oz-Delgado, L. et al. Peripheral immune profile and neutrophil-to-lymphocyte ratio in progressive supranuclear palsy: Case-control study and meta-analysis. Eur. J. Neurol. 31(12), e16451. https:\/\/doi.org\/10.1111\/ene.16451 (2024) (Epub 2024 Aug 20).","journal-title":"Eur. J. Neurol."},{"issue":"1","key":"62325_CR26","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/s12974-018-1248-8","volume":"15","author":"N Kustrimovic","year":"2018","unstructured":"Kustrimovic, N. et al. Parkinson\u2019s disease patients have a complex phenotypic and functional Th1 bias: cross-sectional studies of CD4\u2009+\u2009Th1\/Th2\/T17 and Treg in drug-na\u00efve and drug-treated patients. J. Neuroinflammation. 15(1), 205. https:\/\/doi.org\/10.1186\/s12974-018-1248-8 (2018).","journal-title":"J. Neuroinflammation"},{"issue":"5","key":"62325_CR27","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1002\/mds.29369","volume":"38","author":"L Mu\u00f1oz-Delgado","year":"2023","unstructured":"Mu\u00f1oz-Delgado, L. et al. Peripheral inflammation is associated with dopaminergic degeneration in Parkinson\u2019s disease. Mov. Disord. 38(5), 755\u2013763. https:\/\/doi.org\/10.1002\/mds.29369 (2023) (Epub 2023 Mar 13).","journal-title":"Mov. Disord"},{"key":"62325_CR28","doi-asserted-by":"publisher","first-page":"234","DOI":"10.3389\/fneur.2018.00234","volume":"9","author":"H Sanjari Moghaddam","year":"2018","unstructured":"Sanjari Moghaddam, H., Ghazi Sherbaf, F., Mojtahed Zadeh, M., Ashraf-Ganjouei, A. & Aarabi, M. H. Association between peripheral inflammation and DATSCAN data of the striatal nuclei in different motor subtypes of Parkinson disease. Front. Neurol. 9, 234. https:\/\/doi.org\/10.3389\/fneur.2018.00234 (2018).","journal-title":"Front. Neurol."},{"issue":"1","key":"62325_CR29","doi-asserted-by":"publisher","first-page":"97","DOI":"10.5603\/PJNNS.a2020.0097","volume":"55","author":"P Alster","year":"2021","unstructured":"Alster, P., Madetko, N. & Friedman, A. Neutrophil-to-lymphocyte ratio (NLR) at boundaries of Progressive Supranuclear Palsy Syndrome (PSPS) and Corticobasal Syndrome (CBS). Neurol. Neurochir. Pol. 55(1), 97\u2013101. https:\/\/doi.org\/10.5603\/PJNNS.a2020.0097 (2021) (Epub 2020 Dec 14).","journal-title":"Neurol. Neurochir. Pol."},{"issue":"1","key":"62325_CR30","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1186\/s12883-023-03380-7","volume":"23","author":"S Hosseini","year":"2023","unstructured":"Hosseini, S. et al. Neutrophil to lymphocyte ratio in Parkinson\u2019s disease: a systematic review and meta-analysis. BMC Neurol. 23(1), 333. https:\/\/doi.org\/10.1186\/s12883-023-03380-7 (2023).","journal-title":"BMC Neurol."},{"issue":"5","key":"62325_CR31","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1007\/s13760-019-01197-1","volume":"120","author":"G Kenangil","year":"2020","unstructured":"Kenangil, G., Ari, B. C., Kaya, F. A., Demir, M. & Domac, F. M. Red cell distribution width levels in Parkinson\u2019s disease patients. Acta Neurol. Belg. 120(5), 1147\u20131150. https:\/\/doi.org\/10.1007\/s13760-019-01197-1 (2020) (Epub 2019 Jul 31).","journal-title":"Acta Neurol. Belg."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-62325-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-62325-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-62325-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T11:04:13Z","timestamp":1792494253000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-62325-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,19]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["62325"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-62325-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,19]]},"assertion":[{"value":"12 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Bioethical Committee of Medical University of Warsaw - approval number: KB\/139\/2020. The study was conducted in accordance with the local legislation and institutional requirements. The study was performed in accordance with the Declaration of Helsinki. The participants provided written informed consent to participate in this study.","order":1,"name":"Ethics","label":"Ethical statement","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"32896"}}